BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10025663)

  • 1. Receptor recognition by histidine 16 of human epidermal growth factor via hydrogen-bond donor/acceptor interactions.
    Nandagopal K; Terzaghi-Howe M; Niyogi SK
    J Cell Biochem; 1999 Jan; 72(1):16-24. PubMed ID: 10025663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The functional importance of Leu15 of human epidermal growth factor in receptor binding and activation.
    Nandagopal K; Tadaki DK; Lamerdin JA; Serpersu EH; Niyogi SK
    Protein Eng; 1996 Sep; 9(9):781-8. PubMed ID: 8888144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of asparagine-32 in forming the receptor-binding epitope of human epidermal growth factor.
    Campion SR; Biamonti C; Montelione GT; Niyogi SK
    Protein Eng; 1993 Aug; 6(6):651-9. PubMed ID: 8234236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. pH-dependent receptor/ligand dissociation as a determining factor for intracellular sorting of ligands for epidermal growth factor receptors in rat hepatocytes.
    Maeda K; Kato Y; Sugiyama Y
    J Control Release; 2002 Jul; 82(1):71-82. PubMed ID: 12106978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the high affinity binding site of transforming growth factor-alpha (TGF-alpha) for the chicken epidermal growth factor (EGF) receptor using EGF/TGF-alpha chimeras.
    Kramer RH; Lenferink AE; van Bueren-Koornneef IL; van der Meer A; van de Poll ML; van Zoelen EJ
    J Biol Chem; 1994 Mar; 269(12):8708-11. PubMed ID: 8132599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single amino acid exchange, Arg-45 to Ala, generates an epidermal growth factor (EGF) mutant with high affinity for the chicken EGF receptor.
    van de Poll ML; Lenferink AE; van Vugt MJ; Jacobs JJ; Janssen JW; Joldersma M; van Zoelen EJ
    J Biol Chem; 1995 Sep; 270(38):22337-43. PubMed ID: 7673217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The functional importance of hydrophobicity of the tyrosine at position 13 of human epidermal growth factor in receptor binding.
    Tadaki DK; Niyogi SK
    J Biol Chem; 1993 May; 268(14):10114-9. PubMed ID: 8486681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insertion of Argos sequences into the B-loop of epidermal growth factor results in a low-affinity ligand with strong agonistic activity.
    van de Poll ML; van Vugt MJ; Lenferink AE; van Zoelen EJ
    Biochemistry; 1997 Jun; 36(24):7425-31. PubMed ID: 9200690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-function analysis of a conserved aromatic cluster in the N-terminal domain of human epidermal growth factor.
    Murray MB; Tadaki DK; Campion SR; Lamerdin JA; Serpersu EH; Bradrick TD; Niyogi SK
    Protein Eng; 1998 Nov; 11(11):1041-50. PubMed ID: 9876925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical properties of site-directed mutants of human epidermal growth factor: importance of solvent-exposed hydrophobic residues of the amino-terminal domain in receptor binding.
    Campion SR; Matsunami RK; Engler DA; Niyogi SK
    Biochemistry; 1990 Oct; 29(42):9988-93. PubMed ID: 2271634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interaction of an epidermal growth factor/transforming growth factor alpha tail chimera with the human epidermal growth factor receptor reveals unexpected complexities.
    Puddicombe SM; Wood L; Chamberlin SG; Davies DE
    J Biol Chem; 1996 Nov; 271(48):30392-7. PubMed ID: 8940002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor-binding affinities of human epidermal growth factor variants having unnatural amino acid residues in position 23.
    Koide H; Yokoyama S; Katayama Y; Muto Y; Kigawa T; Kohno T; Takusari H; Oishi M; Takahashi S; Tsukumo K
    Biochemistry; 1994 Jun; 33(23):7470-6. PubMed ID: 8003512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cumulative effect of double-site mutations of human epidermal growth factor on receptor binding.
    Campion SR; Geck MK; Niyogi SK
    J Biol Chem; 1993 Jan; 268(3):1742-8. PubMed ID: 8380576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of the transforming growth factor alpha B-loop beta-sheet to binding and activation of the epidermal growth factor receptor.
    Richter A; Drummond DR; MacGarvie J; Puddicombe SM; Chamberlin SG; Davies DE
    J Biol Chem; 1995 Jan; 270(4):1612-6. PubMed ID: 7829492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recognition of an antiparallel beta-sheet structure of human epidermal growth factor by its receptor. Site-directed mutagenesis studies of Ala-30 and Asn-32.
    Koide H; Muto Y; Kasai H; Hoshi K; Takusari H; Kohri K; Takahashi S; Sasaki T; Tsukumo K; Miyake T
    FEBS Lett; 1992 May; 302(1):39-42. PubMed ID: 1587350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a determinant of epidermal growth factor receptor ligand-binding specificity using a truncated, high-affinity form of the ectodomain.
    Elleman TC; Domagala T; McKern NM; Nerrie M; Lönnqvist B; Adams TE; Lewis J; Lovrecz GO; Hoyne PA; Richards KM; Howlett GJ; Rothacker J; Jorissen RN; Lou M; Garrett TP; Burgess AW; Nice EC; Ward CW
    Biochemistry; 2001 Jul; 40(30):8930-9. PubMed ID: 11467954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilization of a receptor reserve for effective amplification of mitogenic signaling by an epidermal growth factor mutant deficient in receptor activation.
    Nandagopal K; Popp DM; Niyogi SK
    J Cell Biochem; 2001 Aug 1-9; 83(2):326-41. PubMed ID: 11573249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aromaticity at position 37 in human epidermal growth factor is not obligatory for activity.
    Engler DA; Hauser MR; Cook JS; Niyogi SK
    Mol Cell Biol; 1991 May; 11(5):2425-31. PubMed ID: 1850095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical functional requirement for the guanidinium group of the arginine 41 side chain of human epidermal growth factor as revealed by mutagenic inactivation and chemical reactivation.
    Engler DA; Campion SR; Hauser MR; Cook JS; Niyogi SK
    J Biol Chem; 1992 Feb; 267(4):2274-81. PubMed ID: 1733935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracellular trafficking of epidermal growth factor family ligands is directly influenced by the pH sensitivity of the receptor/ligand interaction.
    French AR; Tadaki DK; Niyogi SK; Lauffenburger DA
    J Biol Chem; 1995 Mar; 270(9):4334-40. PubMed ID: 7876195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.